Galantamine Treatment for Nonfluent Aphasia in Stroke Patients

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
AphasiaStroke
Interventions
DRUG

Galantamine

Galantamine XL 8 mg for 4 weeks, followed by Galantamine XL 16 mg for subsequent 12 weeks. Taken in the morning with food for total of 12 weeks.

DRUG

Placebo pill

Placebo pill each morning with food for 12 weeks.

All Listed Sponsors
collaborator

Ortho-McNeil Neurologics, Inc.

INDUSTRY

lead

University of North Carolina, Chapel Hill

OTHER

NCT01129479 - Galantamine Treatment for Nonfluent Aphasia in Stroke Patients | Biotech Hunter | Biotech Hunter